Ann Hynes
Stock Analyst at Mizuho
(4.24)
# 414
Out of 5,238 analysts
291
Total ratings
61.47%
Success rate
11.04%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $52 → $61 | $54.83 | +11.25% | 6 | May 5, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $235 → $265 | $190.38 | +39.20% | 17 | Mar 12, 2026 | |
| MOH Molina Healthcare | Maintains: Outperform | $220 → $180 | $185.94 | -3.19% | 10 | Mar 12, 2026 | |
| ELV Elevance Health | Maintains: Outperform | $413 → $350 | $378.07 | -7.42% | 7 | Mar 11, 2026 | |
| CNC Centene | Maintains: Neutral | $47 → $41 | $55.96 | -26.73% | 10 | Mar 11, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $14.44 | +17.73% | 5 | Mar 5, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $435.19 | +34.42% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $177.62 | -1.48% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $187.39 | +25.41% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $379.98 | -7.89% | 22 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $13 | $15.43 | -15.75% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $12 | $10.11 | +18.69% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $25.18 | -32.49% | 13 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $90.55 | +4.91% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $424.00 | +54.48% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $254.12 | +25.92% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $274.96 | +25.47% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $178.71 | +25.90% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $124.49 | +80.74% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.51 | -36.20% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $183.65 | -34.66% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $24.16 | +15.89% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $106.10 | -10.46% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $288.06 | +33.65% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $169.96 | +17.67% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.20 | +22,233.33% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $736.09 | -31.39% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.84 | +6,695.42% | 1 | Sep 21, 2017 |
BrightSpring Health Services
May 5, 2026
Maintains: Outperform
Price Target: $52 → $61
Current: $54.83
Upside: +11.25%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235 → $265
Current: $190.38
Upside: +39.20%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220 → $180
Current: $185.94
Upside: -3.19%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413 → $350
Current: $378.07
Upside: -7.42%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47 → $41
Current: $55.96
Upside: -26.73%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $14.44
Upside: +17.73%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $435.19
Upside: +34.42%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $177.62
Upside: -1.48%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $187.39
Upside: +25.41%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $379.98
Upside: -7.89%
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $15.43
Upside: -15.75%
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $10.11
Upside: +18.69%
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $25.18
Upside: -32.49%
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $90.55
Upside: +4.91%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $424.00
Upside: +54.48%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $254.12
Upside: +25.92%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $274.96
Upside: +25.47%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $178.71
Upside: +25.90%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $124.49
Upside: +80.74%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $23.51
Upside: -36.20%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $183.65
Upside: -34.66%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $24.16
Upside: +15.89%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $106.10
Upside: -10.46%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $288.06
Upside: +33.65%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $169.96
Upside: +17.67%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.20
Upside: +22,233.33%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $736.09
Upside: -31.39%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.84
Upside: +6,695.42%